Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Zymergen, Inc.

NEW YORK, NY / ACCESSWIRE / Aug 11, 2021 / Bernstein Liebhard, a nationally recognized investor rights law firm, is reminding investors of the deadline to file a lead plaintiff motion in a securities class action filed on behalf of investors purchasing the securities of Zymergen Inc. (‘Zymergen’ or the “Company”) (NASDAQ : ZY) from April 20, 2021 to August 4, 2021 (the “Class Period”). The lawsuit filed in the U.S. District Court for the Northern District of California alleges violations of the Securities Act of 1933.

if you Have purchased Zymergen securities and / or wish to discuss your legal rights and options please visit Zymergen Shareholder Class Action or contact Rujul Patel toll-free at (877) 779-1414 or [email protected]

The allegations stem from the misrepresentation in Zymergen’s registration statement for its IPO on April 23, 2021. The complaint alleges that while the registration statement highlights the entire addressable market for Hyaline, Zymergen’s key product, it omitted that ( 1) key customers encountered technical problems during the qualification process, including product shrinkage and incompatibility with customer processes; (2) Zymergen had no insight into the qualification process; (3) the company had overestimated the demand for its products; and (4) the schedule for product delivery would be delayed, adversely affecting revenue generation.

On August 3, 2021, Zymergen announced that it became aware of various issues with its commercial product pipeline that are affecting delivery times and sales projections. Zymergen further announced that no product sales are expected in 2021 and no product sales in 2022. In addition, several large customers were unable to use Hyaline in their manufacturing processes.

As a result of this news, Zymergen stock fell $ 26.58 per share, or 76%, to close at $ 8.25 per share on August 4, 2021.

The story goes on

If you want to serve as the lead plaintiff, you must call the court no later than October 4, 2021. A lead plaintiff is a representative party who acts on behalf of other class members in the conduct of the dispute. Your ability to partake in a recovery does not require you to be the lead plaintiff. If you do nothing, you can remain an absent class member.

if you Have purchased Zymergen securities and / or wish to discuss your legal rights and options please visit https://www.bernlieb.com/cases/zymergeninc-zy-shareholder-class-action-lawsuit-fraud-stock-426/apply/ or contact Rujul Patel toll-free at (877) 779-1414 or [email protected]

Since 1993, Bernstein Liebhard LLP has recovered over $ 3.5 billion for its clients. In addition to representing individual investors, the firm has been hired by some of the country’s largest public and private pension funds to monitor their assets and litigate on their behalf. As a result of its success in hundreds of lawsuits and class actions, the firm has been included on the National Law Journal’s “Plaintiffs’ Hot List” thirteen times and on The Legal 500 for ten consecutive years.

ADVERTISING LAWYER. © 2021 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The attorney responsible for this complaint in the Connecticut state is Michael S. Bigin. Past results do not guarantee or predict a similar result with respect to future matters.

Contact information

Patel lipstick
Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
[email protected]

SOURCE: Bernstein Liebhard LLP

View source version on accesswire.com:
https://www.accesswire.com/659335/ZY-INVESTOR-ALERT-Bernstein-Liebhard-LLP-Reminds-Investors-of-the-Deadline-to-File-a-Lead-Plaintiff-Motion-in-a- Security-Class-Action-Lawsuit-Against-Zymergen-Inc

Comments are closed.